Tag: Policy
AiMeD applauds govt’s latest MedTech policy decisions
These include National Medical Devices Policy 2023; Medical Devices Export Promotion Council; and Scheme for Assistance to Medical Devices Clusters for common facility
Dr Jitendra Kumar appointed as new MD of BIRAC
In his previous stint as the Managing Director of Bangalore Bioinnovation Centre (BBC) for more than eight years, he was instrumental in nurturing many startups and innovations
US$ 300 billion industry by 2030: Time to move out of...
For a successful scientific ecosystem to deliver, there are three important pillars — capacity, cutting edge technologies & collaboration, writes Dr Renu Swarup, Former Secretary, Department of Biotechnology
India aims to become a global leader in medical devices with...
The National Medical Device Policy 2023 aims to strengthen the medical devices industry, making it more competitive, self-reliant, resilient, and innovative
Decoding govt’s new policy for medical devices sector
Policy is expected to help the Medical Devices Sector, grow from present $11 Bn to $50 Bn in next five years
Malaria No More brings together key stakeholders to develop comprehensive malaria...
Despite progress in reducing malaria’s burden in the state, there is still much work to be done to achieve the goal of malaria elimination
ABLE’s 20th Anniversary: Realistic policies & regulations critical for bioeconomy to...
Kiran was speaking at the 20th Anniversary Celebration of the Association of Biotechnology Led Enterprises (ABLE) on April 07, 2023. The theme of the event was "India-A Resilient Global Biotech Destination."
Goa’s medical services setting an example towards achieving India’s G20 priorities
State’s Immunization model an excellent example of well-organized and effective use of technology to ensure that every child is immunized in a timely manner
Incentivizing agri-seed R&D key to food security
As opined by the Federation of Seed Industry of India (FSII), the Indian seed industry is valued at approximately INR 22,000 crore and registering growth year-on-year
MTaI recommends Japan as the “China+1 alternative in MedTech imports
Increase in MedTech imports from China by 57% in FY 21-22 raise concerns